文献速递高血压心律失常瓣膜病与结构性心脏病

癌症治疗的心血管并发症:诊断、预防和管理的最佳实践(下)

Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

本综述基于MEDLINE检索、已发表临床指南及主要癌症中心最佳实践,聚焦癌症或其治疗相关的系统性及肺动脉高压、QT间期延长、心律失常、心包疾病和放疗心脏毒性。新型靶向治疗可产生脱靶效应导致高血压、血栓栓塞、QT间期延长和房颤,放疗常加速动脉粥样硬化并损伤心脏瓣膜、传导系统及心包且可能数年才显现。综述强调心内科医生需熟悉这一新兴亚专科。

要点

  • 靶向治疗脱靶效应可致高血压、血栓栓塞、QT延长和房颤
  • 放疗加速动脉粥样硬化并损伤瓣膜、传导系统及心包,临床显现可能延迟数年
  • 癌症患者心包疾病的管理也构成临床挑战

核心结论

  • 癌症或其治疗可导致多种心血管并发症,心内科医生应熟悉这一新兴亚专科。

研究设计与样本

  • 综述的第二部分,基于MEDLINE检索的已发表数据、已发表临床指南及主要癌症中心的最佳实践。

主要发现

  • 新型靶向治疗可产生脱靶效应导致高血压、血栓栓塞、QT间期延长和房颤。
  • 放疗常加速动脉粥样硬化,并可损伤心脏瓣膜、传导系统及心包,可能数年才临床显现。

临床怎么用

  • 心内科医生应了解癌症治疗相关心血管并发症的诊断、预防和管理最佳实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In this second part of a 2-part review, we will review cancer or cancer therapy-associated systemic and pulmonary hypertension, QT prolongation, arrhythmias, pericardial disease, and radiation-induced cardiotoxicity. This review is based on a MEDLINE search of published data, published clinical guidelines, and best practices in major cancer centers. Newly developed targeted therapy can exert off-target effects causing hypertension, thromboembolism, QT prolongation, and atrial fibrillation. Radiation therapy often accelerates atherosclerosis. Furthermore, radiation can damage the heart valves, the conduction system, and pericardium, which may take years to manifest clinically. Management of pericardial disease in cancer patients also posed clinical challenges. This review highlights the unique opportunity of caring for cancer patients with heart problems caused by cancer or cancer therapy. It is an invitation to action for cardiologists to become familiar with this emerging subspecialty.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Chang HM, Okwuosa TM, Scarabelli T, et al. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2. J Am Coll Cardiol. 2017. PMID: 29145955. doi:10.1016/j.jacc.2017.09.1095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。